Equillium, Inc. (EQ) Dividend History

Equillium, Inc. (EQ) is a biotechnology company focused on developing therapies for severe autoimmune and inflammatory diseases. The company specializes in novel immunotherapies that target the underlying immune mechanisms contributing to conditions such as transplantation rejection, autoimmune disorders, and inflammatory diseases.

2223 Avenida De La Playa, La Jolla, CA, 92037
Phone: (858) 412-5302
Website: https://www.equilliumbio.com
Dividend Yield: 667.48%
Dividend Frequency: Quarterly

Dividend History

Pay Date Amount Ex Dividend Date Record Date
June 30, 2009 $0.69 06/12/2009 06/16/2009
March 31, 2009 $0.69 03/13/2009 03/17/2009
December 31, 2008 $0.69 12/08/2008 12/10/2008
September 30, 2008 $0.69 09/05/2008 09/09/2008
June 30, 2008 $0.69 06/05/2008 06/09/2008
Show more

Dividends Summary

  • Equillium, Inc. has issued 12 dividend payments over the past 3 years
  • The most recent dividend was paid 5868 days ago, on June 30, 2009
  • The first recorded dividend was paid on September 30, 2006
  • The highest dividend payout was $0.69 per share
  • The average dividend over this 3 year span is $0.62 per share
  • Equillium, Inc. has increased its dividend payments by 37.50% since 2006

Company News

  • The graft versus host disease market is experiencing significant growth, driven by the adoption of branded therapies, a strong pipeline with the anticipated launch of over 10 new drugs, and increased awareness of GvHD management. Innovative treatments and ongoing research are expected to further expand market opportunities.

    GlobeNewswire Inc.
    Featured Companies: BMY INCY MCRB PFE SNDX
  • Equillium (EQ) delivered earnings and revenue surprises of 52.94% and 16.82%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: INO
  • Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share. Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Stoke Therapeutics, Inc. (NASDAQ: STOK) shares gained 72.6% to $11.24 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. C3is Inc. (NASDAQ: CISS) climbed 65% to $0.0581 after the company reported a year-over-year increase in fourth-quarter financial results. OpGen, Inc. (NASDAQ: OPGN) shares climbed 48.2% to $0.7039 after the company entered into a securities purchase agreement with a private investor, David Lazar, to acquire 3 million shares of Series E Convertible Preferred Stock at $1.00 per share for aggregate gross proceeds of $3.0 million. Mesoblast Limited (NASDAQ: MESO) gained 43.2% to $3.1501. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease. Praxis Precision Medicines Inc (NASDAQ: PRAX) gained 31.9% to $66.63 after the company reported results from a Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR. Nuvation Bio Inc (NYSE: NUVB) climbed 24.4% to $2.80 after BTIG upgraded the stock from Neutral to Buy. Check-Cap Ltd. (NASDAQ: CHEK) shares gained 24.3% to $2.40 after the company announced that it entered into a definitive Business Combination Agreement with Nobul AI. Viking Therapeutics ...

    Benzinga
Page data last updated 07/23/2025 20:20:58 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included